SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-004492
Filing Date
2017-05-12
Accepted
2017-05-12 08:32:10
Documents
39
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT opxa_10q.htm 10-Q 563242
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit311.htm EX-31.1 13158
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit321.htm EX-32.1 7497
4 IMAGE opxa_10q000.jpg GRAPHIC 1738
  Complete submission text file 0001654954-17-004492.txt   1578462

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT opxa-20170331.xml EX-101.INS 107820
6 XBRL TAXONOMY EXTENSION SCHEMA opxa-20170331.xsd EX-101.SCH 28313
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opxa-20170331_cal.xml EX-101.CAL 29188
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opxa-20170331_def.xml EX-101.DEF 40120
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE opxa-20170331_lab.xml EX-101.LAB 150345
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opxa-20170331_pre.xml EX-101.PRE 110644
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 17836506
SIC: 2834 Pharmaceutical Preparations